KTH Royal Institute of Technology in Stockholm has grown to become one of Europe’s leading technical and engineering universities, as well as a key centre of intellectual talent and innovation. We are Sweden’s largest technical research and learning institution and home to students, researchers and faculty from around the world. Our research and education covers a wide area including natural sciences and all branches of engineering, as well as architecture, industrial management, urban planning, history and philosophy.
SciLifeLab is a national resource center dedicated to large scale bioscientific research with focus on biomedicine, including genome and proteome profiling, bioimaging and bioinformatics. SciLifeLab Stockholm has been formed jointly by the three Stockholm universities, Royal Institute of Technology (KTH), Karolinska Institutet (KI) and Stockholm University (SU), and thus combines the profiles and strengths of these three institutions. Academic research as well as the Swedish health care system and the Swedish Life Science industry will benefit through active collaboration, access to advanced tools and active programs for knowledge transfer. The goal is to achieve critical mass for large-scale life sciences and translational medicine.
School of Engineering Sciences in Chemistry, Biotechnology and Health.
Mardinoglu lab at SciLifeLab develop genome-scale metabolic models (GEMs) for human cells/tissues and employ these comprehensive models in the analysis of the omics data obtained from subjects with complex diseases including non-alcoholic fatty liver disease, type 2 diabetes and certain types of cancer (e.g. hepatocellular carcinoma). This is an exciting area of biomedical research, driven by the recent discoveries of metabolic reprogramming in common complex diseases.
The candidates are expected to perform research in Systems Biology, Systems Medicine, Network Medicine and Bioinformatics
The candidates will integrate the liver GEMs with other biological networks including regulatory, protein-protein interactions (PPIs) and co-expression networks. The candidate will use these biological networks in the analysis of the omics data obtained from different clinical conditions to identify drug targets and discover biomarker for the development of the efficient diagnostic and treatment strategies for liver diseases including non-alcoholic steatohepatitis and hepatocellular carcinoma.
The candidates will also use systems biology tools to perform identify potential drugs for treatment of the disease which will be later validated in the lab.
The candidate will be working closely with the experimental groups as well as clinicians. More information can be found at sysmedicine.com
Great emphasis will be placed on personal competence and suitability.
Apply to this scholarship by e-mail HR representative Jenny Söderborg firstname.lastname@example.org
You are the main responsible to ensure that your application is complete according to the ad. Your complete application must be received at KTH no later than 2021-03-18. Mark the e-mail subject line and application with reference number C-2021-0233.
The application must include the following documents:
Please observe that you apply for a scholarship, not an employment
Period: From October 2021 (flexible start). 1+1 (1 year with possibility to be prolonged another year.
Amount of scholarship: 27 000 SEK/month, (payment according KTH policy for scholarship)
Location: Science for Life Laboratory, Stockholm
Doctor Cheng Zhang, e-mail: email@example.com
Associated Professor Adil Mardinoglu, e-mail: firstname.lastname@example.org
We firmly decline all contact with staffing and recruitment agencies and job ad salespersons.